Skip to main content
. 2002 Jun;40(6):1930–1937. doi: 10.1128/JCM.40.6.1930-1937.2002

TABLE 2.

Resistance to antituberculosis drugs of M. tuberculosis strains isolated from 119 patients in Archangels Oblast, Russia, in 1998 and 1999, according to genotype and clustering

Resistance Genotype
Clustering
No. (%) of strains
OR (95% CI) P No. (%) of strains that were:
OR (95% CI) P
Total Of the following genotype:
Clustered (n = 71) Nonclustered (n = 48)
Beijing (n = 53) Non-Beijing (n = 66)
Ethambutol 38 (31.9) 22 (41.5) 16 (24.2) 2.2 (1.0-5.3) 0.04 28 (39.4) 10 (20.8) 2.5 (1.0-6.3) 0.03
Isoniazid 55 (46.2) 33 (62.3) 22 (33.3) 3.3 (1.4-7.6) 0.001 42 (59.2) 13 (27.1) 3.9 (1.6-9.4) 0.001
Rifampin 30 (25.2) 23 (43.4) 7 (10.6) 6.5 (2.3-19.0) <0.001 27 (38.0) 3 (6.3) 9.2 (2.4-41.7) <0.001
Streptomycin 56 (47.1) 39 (73.6) 17 (25.8) 8.0 (3.3-20.2) <0.001 45 (63.4) 11 (22.9) 5.8 (2.4-14.7) <0.001
Any one drug 67 (56.3) 41 (77.4) 26 (39.4) 5.3 (2.2-13.0) <0.001 50 (70.4) 17 (35.4) 4.3 (1.8-10.4) <0.001
MDR 30 (25.2) 23 (43.4) 7 (10.6) 6.5 (2.3-19.0) <0.001 27 (38.0) 3 (6.3) 9.2 (2.4-41.7) <0.001